AAAAAA

   
Results: 1-23 |
Results: 23
CD34(-) CELLS INFLUENCE DAYS TO ENGRAFTMENT AND TRANSFUSION REQUIREMENTS IN AUTOLOGOUS BLOOD STEM-CELL RECIPIENTS()CD33()
Authors: PECORA AL PRETI RA GLEIM GW JENNIS A ZAHOS K CANTWELL S DORIA L ISAACS R GILLIO AP MICHELIS MA BROCHSTEIN JA
Citation: Al. Pecora et al., CD34(-) CELLS INFLUENCE DAYS TO ENGRAFTMENT AND TRANSFUSION REQUIREMENTS IN AUTOLOGOUS BLOOD STEM-CELL RECIPIENTS()CD33(), Journal of clinical oncology, 16(6), 1998, pp. 2093-2104
HIGH-DOSE INDUCTION CHEMORADIOTHERAPY FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION AS CONSOLIDATION THERAPY IN RHABDOMYOSARCOMA, EXTRAOSSEOUS EWINGS-SARCOMA, AND UNDIFFERENTIATED SARCOMA
Authors: BOULAD F KERNAN NA LAQUAGLIA MP HELLER G LINDSLEY KL ROSENFIELD NS ABRAMSON SJ GERALD WL SMALL TN GILLIO AP GULATI SC OREILLY RJ GHAVIMI F
Citation: F. Boulad et al., HIGH-DOSE INDUCTION CHEMORADIOTHERAPY FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION AS CONSOLIDATION THERAPY IN RHABDOMYOSARCOMA, EXTRAOSSEOUS EWINGS-SARCOMA, AND UNDIFFERENTIATED SARCOMA, Journal of clinical oncology, 16(5), 1998, pp. 1697-1706
T-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION AS POSTREMISSION THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA - FREEDOM FROM RELAPSE IN THE ABSENCE OF GRAFT-VERSUS-HOST DISEASE
Authors: PAPADOPOULOS EB CARABASI MH CASTROMALASPINA H CHILDS BH MACKINNON S BOULAD F GILLIO AP KERNAN NA SMALL TN SZABOLCS P TAYLOR J YAHALOM J COLLINS NH BLEAU SA BLACK PM HELLER G OREILLY RJ YOUNG JW
Citation: Eb. Papadopoulos et al., T-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION AS POSTREMISSION THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA - FREEDOM FROM RELAPSE IN THE ABSENCE OF GRAFT-VERSUS-HOST DISEASE, Blood, 91(3), 1998, pp. 1083-1090
RISK OF EXTRAMEDULLARY RELAPSE FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA WITH LEUKEMIA-CUTIS
Authors: MICHEL G BOULAD F SMALL TN BLACK P HELLER G CASTROMALASPINA H CHILDS BH GILLIO AP PAPADOPOULOS EB YOUNG JW KERNAN NA OREILLY RJ
Citation: G. Michel et al., RISK OF EXTRAMEDULLARY RELAPSE FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA WITH LEUKEMIA-CUTIS, Bone marrow transplantation, 20(2), 1997, pp. 107-112
PHARMACOKINETICS AND ACUTE TOXICOLOGY OF INTRAVENTRICULAR I-131 MONOCLONAL-ANTIBODY TARGETING DISIALOGANGLIOSIDE IN NONHUMAN-PRIMATES
Authors: KRAMER K CHEUNG NKV HUMM J DIRESTA G ARBIT E LARSON S FINN R ROSENBLUM M NGUYEN H GONZALEZ G LIU CJ YANG YF MENDELSOHN ME GILLIO AP
Citation: K. Kramer et al., PHARMACOKINETICS AND ACUTE TOXICOLOGY OF INTRAVENTRICULAR I-131 MONOCLONAL-ANTIBODY TARGETING DISIALOGANGLIOSIDE IN NONHUMAN-PRIMATES, Journal of neuro-oncology, 35(2), 1997, pp. 101-111
PHENOTYPIC CONSEQUENCES OF MUTATIONS IN THE FANCONI-ANEMIA FAC GENE -AN INTERNATIONAL-FANCONI-ANEMIA-REGISTRY STUDY
Authors: GILLIO AP VERLANDER PC BATISH SD GIAMPIETRO PF AUERBACH AD
Citation: Ap. Gillio et al., PHENOTYPIC CONSEQUENCES OF MUTATIONS IN THE FANCONI-ANEMIA FAC GENE -AN INTERNATIONAL-FANCONI-ANEMIA-REGISTRY STUDY, Blood, 90(1), 1997, pp. 105-110
CORRECTION OF CONGENITAL ERYTHROPOIETIC PORPHYRIA BY ALLOGENEIC MARROW TRANSPLANTATION
Authors: BROCHSTEIN JA GILLIO AP POHFITZPATRICK MB DORIA L BESTAK M
Citation: Ja. Brochstein et al., CORRECTION OF CONGENITAL ERYTHROPOIETIC PORPHYRIA BY ALLOGENEIC MARROW TRANSPLANTATION, Blood, 88(10), 1996, pp. 2466-2466
THE EXTENT AND TIMING OF EARLY (CD34-) HEMATOPOIETIC PROGENITOR MOBILIZATION FOLLOWING CHEMOTHERAPY AND(CD33)OR PRIMING/
Authors: PECORA AL ZAHOS KM JENNIS A ISAACS RE CANTWELL S MICHELIS AM GILLIO AP BROCHSTEIN JA
Citation: Al. Pecora et al., THE EXTENT AND TIMING OF EARLY (CD34-) HEMATOPOIETIC PROGENITOR MOBILIZATION FOLLOWING CHEMOTHERAPY AND(CD33)OR PRIMING/, Blood, 88(10), 1996, pp. 2702-2702
THERAPEUTIC USE OF CYTOKINES IN CHILDREN
Authors: GUINAN EC GILLIO AP
Citation: Ec. Guinan et Ap. Gillio, THERAPEUTIC USE OF CYTOKINES IN CHILDREN, International journal of pediatric hematology/oncology, 2(2), 1995, pp. 85-85
CYTOKINE TREATMENT OF INHERITED BONE-MARROW FAILURE SYNDROMES
Authors: GILLIO AP GUINAN EC
Citation: Ap. Gillio et Ec. Guinan, CYTOKINE TREATMENT OF INHERITED BONE-MARROW FAILURE SYNDROMES, International journal of pediatric hematology/oncology, 2(2), 1995, pp. 125-133
ADOPTIVE IMMUNOTHERAPY EVALUATING ESCALATING DOSES OF DONOR LEUKOCYTES FOR RELAPSE OF CHRONIC MYELOID-LEUKEMIA AFTER BONE-MARROW TRANSPLANTATION - SEPARATION OF GRAFT-VERSUS-LEUKEMIA RESPONSES FROM GRAFT-VERSUS-HOST DISEASE
Authors: MACKINNON S PAPADOPOULOS EB CARABASI MH REICH L COLLINS NH BOULAD F CASTROMALASPINA H CHILDS BH GILLIO AP KERNAN NA SMALL TN YOUNG JW OREILLY RJ
Citation: S. Mackinnon et al., ADOPTIVE IMMUNOTHERAPY EVALUATING ESCALATING DOSES OF DONOR LEUKOCYTES FOR RELAPSE OF CHRONIC MYELOID-LEUKEMIA AFTER BONE-MARROW TRANSPLANTATION - SEPARATION OF GRAFT-VERSUS-LEUKEMIA RESPONSES FROM GRAFT-VERSUS-HOST DISEASE, Blood, 86(4), 1995, pp. 1261-1268
EVALUATION OF IN-VITRO EXPRESSION OF MFGFAC RECOMBINANT RETROVIRUS INPROGENITORS OF PATIENTS WITH FANCONI-ANEMIA TYPE-C (FAC) DEFECT AND IN RECONSTITUTED MICE IN-VIVO
Authors: FREIE B AUERBACH AD GILLIO AP CLAPP DW
Citation: B. Freie et al., EVALUATION OF IN-VITRO EXPRESSION OF MFGFAC RECOMBINANT RETROVIRUS INPROGENITORS OF PATIENTS WITH FANCONI-ANEMIA TYPE-C (FAC) DEFECT AND IN RECONSTITUTED MICE IN-VIVO, Blood, 86(10), 1995, pp. 973-973
PHENOTYPIC CONSEQUENCES OF MUTATIONS IN THE FANCONI-ANEMIA FAC GENE
Authors: GILLIO AP VERLANDER PC BATISH SD GIAMPIETRO PF AUERBACH AD
Citation: Ap. Gillio et al., PHENOTYPIC CONSEQUENCES OF MUTATIONS IN THE FANCONI-ANEMIA FAC GENE, Blood, 86(10), 1995, pp. 1889-1889
PHENOTYPIC CONSEQUENCES OF THE ASHKENAZI JEWISH MUTATION IVS4 -]T IN THE FANCONI-ANEMIA GENE FAC - AN INTERNATIONAL FANCONI-ANEMIA REGISTRY(IFAR) STUDY(4 A)
Authors: AUERBACH AD GILLIO AP GIAMPIETRO PF VERLANDER PC
Citation: Ad. Auerbach et al., PHENOTYPIC CONSEQUENCES OF THE ASHKENAZI JEWISH MUTATION IVS4 -]T IN THE FANCONI-ANEMIA GENE FAC - AN INTERNATIONAL FANCONI-ANEMIA REGISTRY(IFAR) STUDY(4 A), American journal of human genetics, 57(4), 1995, pp. 1357-1357
DYSHEMATOPOIESIS IN COMBINED IMMUNE-DEFICIENCY WITH CONGENITAL NEUTROPENIA
Authors: GASPARETTO C SMITH C FIRPO M DENNIG D SMALL T GILLIO AP LICHTENBERG R OREILLY RJ MOORE MAS
Citation: C. Gasparetto et al., DYSHEMATOPOIESIS IN COMBINED IMMUNE-DEFICIENCY WITH CONGENITAL NEUTROPENIA, American journal of hematology, 45(1), 1994, pp. 63-72
MULTIORGAN SYSTEM FAILURE SYNDROME IN PATIENTS UNDERGOING MYELOABLATIVE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW RESCUE FOR MALIGNANT BRAIN-TUMORS
Authors: GEORGE D GINSBERG I WEINGAST R PAPADAKIS V GILLIO AP PAPADOPOULOS E HELLER G FINLAY JL
Citation: D. George et al., MULTIORGAN SYSTEM FAILURE SYNDROME IN PATIENTS UNDERGOING MYELOABLATIVE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW RESCUE FOR MALIGNANT BRAIN-TUMORS, Experimental hematology, 22(8), 1994, pp. 779-779
INFUSIONS OF DONOR LEUKOCYTES TO TREAT EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: PAPADOPOULOS EB LADANYI M EMANUEL D MACKINNON S BOULAD F CARABASI MH CASTROMALASPINA H CHILDS BH GILLIO AP SMALL TN YOUNG JW KERNAN NA OREILLY RJ
Citation: Eb. Papadopoulos et al., INFUSIONS OF DONOR LEUKOCYTES TO TREAT EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, The New England journal of medicine, 330(17), 1994, pp. 1185-1191
LACTIC-ACIDOSIS AND RENAL ENLARGEMENT AT DIAGNOSIS AND RELAPSE OF ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: ALI AA FLOMBAUM CD BROCHSTEIN JA GILLIO AP BUSSEL JB BOULAD F
Citation: Aa. Ali et al., LACTIC-ACIDOSIS AND RENAL ENLARGEMENT AT DIAGNOSIS AND RELAPSE OF ACUTE LYMPHOBLASTIC-LEUKEMIA, The Journal of pediatrics, 125(4), 1994, pp. 584-586
HEMATOLOGIC ABNORMALITIES IN FANCONI-ANEMIA - AN INTERNATIONAL FANCONI-ANEMIA REGISTRY STUDY
Authors: BUTTURINI A GALE RP VERLANDER PC ADLERBRECHER B GILLIO AP AUERBACH AD
Citation: A. Butturini et al., HEMATOLOGIC ABNORMALITIES IN FANCONI-ANEMIA - AN INTERNATIONAL FANCONI-ANEMIA REGISTRY STUDY, Blood, 84(5), 1994, pp. 1650-1655
IMPROVED DISEASE-FREE SURVIVAL IN RECIPIENTS OF T CELL-DEPLETED (SBA-E-) BONE-MARROW ALLOGRAFTS FOR ACUTE NONLYMPHOCYTIC LEUKEMIA IN 1ST REMISSION
Authors: PAPADOPOULOS EB BOULAD F CARABASI MH CASTROMALASPINA H CHILDS BH COLLINS NH EMANUEL D GILLIO AP KERNAN NA MACKINNON S SMALL TN LINDSLEY K YAHALOM J BLEAU S BLACK P HELLER G OREILLY RJ YOUNG JW
Citation: Eb. Papadopoulos et al., IMPROVED DISEASE-FREE SURVIVAL IN RECIPIENTS OF T CELL-DEPLETED (SBA-E-) BONE-MARROW ALLOGRAFTS FOR ACUTE NONLYMPHOCYTIC LEUKEMIA IN 1ST REMISSION, Blood, 84(10), 1994, pp. 10000331-10000331
SUCCESSFUL TREATMENT OF DIAMOND-BLACKFAN ANEMIA WITH INTERLEUKIN-3
Authors: GILLIO AP FAULKNER LB ALTER BP REILLY L KLAFTER R HELLER G YOUNG DC LIPTON JM MOORE MAS OREILLY RJ
Citation: Ap. Gillio et al., SUCCESSFUL TREATMENT OF DIAMOND-BLACKFAN ANEMIA WITH INTERLEUKIN-3, Stem cells, 11, 1993, pp. 123-130
EFFECT OF STEM-CELL FACTOR (SCF) ON IN-VITRO ERYTHROPOIESIS IN PATIENTS WITH BONE-MARROW FAILURE SYNDROMES (BMFS)
Authors: WEINBERG RS KNOBLOCH ME HE LY GILLIO AP OREILLY RJ REILLY LK ALTER BP
Citation: Rs. Weinberg et al., EFFECT OF STEM-CELL FACTOR (SCF) ON IN-VITRO ERYTHROPOIESIS IN PATIENTS WITH BONE-MARROW FAILURE SYNDROMES (BMFS), Experimental hematology, 21(5), 1993, pp. 723-723
TREATMENT OF DIAMOND-BLACKFAN ANEMIA WITH RECOMBINANT HUMAN INTERLEUKIN-3
Authors: GILLIO AP FAULKNER LB ALTER BP REILLY L KLAFTER R HELLER G YOUNG DC LIPTON JM MOORE MAS OREILLY RJ
Citation: Ap. Gillio et al., TREATMENT OF DIAMOND-BLACKFAN ANEMIA WITH RECOMBINANT HUMAN INTERLEUKIN-3, Blood, 82(3), 1993, pp. 744-751
Risultati: 1-23 |